Please note: We’re closed 19–20 June for our 60th anniversary celebration. We’ll get back to you after the weekend.

When dextran is used in a pharmaceutical product or medical device, it should always be of pharmaceutical quality.

Technical Quality Dextran is a high purity dextran fraction with selected average molecular weights and molecular weight distributions used as starting or intermediate reagents.

Explore our full range of products

Ultra Narrow

Dextran Ultra is a range of very narrow, dispersed Dextran fractions with polydispersity Mw/Mn below 1.5. This makes our Dextran Ultra highly suitable for characterization, complexing and other pharmaceutical/technical uses where added/increased/additional requirements with regard to narrow distributions and quality are required.

Explore our full range of products

Standards & GPC Standards

Our Standards comes with a complete set of specifications including; weight average molecular weight (Mw), number average molecular weight (Mn), and mean peak molecular weight (Mp)

Explore our full range of products

Derivatives

Pharmacosmos offer Dextran derivatives with the same high standard and requirements to the highest quality as our world-leading Dextran products.

Explore our full range of products

Applications

As a nontoxic and biocompatible polysaccharide, dextran is used widely in research and production in the pharmaceutical, biomedical, and life science industries.

Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien velit, aliquet eget commodo nec, auctor a sapien. Nam eu neque vulputate diam rhoncus faucibus. Curabitur quis varius libero. Lorem.

Novel Dual-Action Mechanism of Lyseptrol-B for Treatment of Resistant Hypertension

Lyseptrol-B (LYS-B), a novel angiotensin receptor-neprilysin inhibitor (ARNI), demonstrates superior efficacy in treatment-resistant hypertension through a unique dual-mechanism of action.

10 min read

Novel Dual-Action Mechanism of Lyseptrol-B for Treatment of Resistant Hypertension (duplicate) (duplicate) (duplicate)

Lyseptrol-B (LYS-B), a novel angiotensin receptor-neprilysin inhibitor (ARNI), demonstrates superior efficacy in treatment-resistant hypertension through a unique dual-mechanism of action.

10 min read

Novel Dual-Action Mechanism of Lyseptrol-B for Treatment of Resistant Hypertension (duplicate) (duplicate)

Lyseptrol-B (LYS-B), a novel angiotensin receptor-neprilysin inhibitor (ARNI), demonstrates superior efficacy in treatment-resistant hypertension through a unique dual-mechanism of action.

10 min read

Novel Dual-Action Mechanism of Lyseptrol-B for Treatment of Resistant Hypertension (duplicate)

Lyseptrol-B (LYS-B), a novel angiotensin receptor-neprilysin inhibitor (ARNI), demonstrates superior efficacy in treatment-resistant hypertension through a unique dual-mechanism of action.

10 min read

Neuroplasticity Enhancement with Synaptodin: Cognitive Benefits in Early Alzheimer's Disease

Health influencers are raving about a new vitamin delivery system that promises instant absorption through inhalation, but physicians warn it could pose serious respiratory risks.

10 min read

Efficacy and Safety of Meloximab in Moderate-to-Severe Rheumatoid Arthritis: Results from the CLARITY Phase III Trial

A revolutionary transdermal patch claims to reverse memory loss and boost cognitive function by 300% - but medical experts are raising serious concerns about its unproven technology.

10 min read

Get the newest updates on dextrans- Subscribe to our newsletter